Biochemistry and suicidal behavior in depressed patients (original) (raw)

HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters

Jussi Jokinen

Journal of Affective Disorders, 2008

View PDFchevron_right

Neurobiological aspect of suicide; a review of low cerebrospinal 5 hydroxyindoleacetic acid concentration and prediction of suicidality

Almira Osmanovic Thunstrom

View PDFchevron_right

Recent biologic studies on suicide

Alex Roy

Suicide & life-threatening behavior, 1994

View PDFchevron_right

The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention

Marco Innamorati

European Archives of Psychiatry and Clinical Neuroscience, 2010

View PDFchevron_right

A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder

Michael Grunebaum

Bipolar Disorders, 2006

View PDFchevron_right

Neurochemical Correlates of Suicidal Behavior: Involvement of Serotonergic and Non-Serotonergic Systems

Mark Underwood

Pharmacology & Toxicology, 1990

View PDFchevron_right

The Neurobiology and Genetics of Suicide and Attempted Suicide: A Focus on the Serotonergic System

Victoria Arango

Neuropsychopharmacology, 2001

View PDFchevron_right

Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression

Nikola Kern

Biological Psychiatry, 2005

View PDFchevron_right

CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence

Michael Grunebaum

European Neuropsychopharmacology, 2007

View PDFchevron_right

The Involvement of Hypothalamus–Pituitary–Adrenal (HPA) Axis in Suicide Risk

I. Berardelli

Brain Sciences, 2020

View PDFchevron_right

CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters

Jussi Jokinen, Stefan Arver

European Neuropsychopharmacology, 2013

View PDFchevron_right

Hypothalamic-Pituitary-Adrenal Axis and Suicide

Csaba M. Banki

Annals of the New York Academy of Sciences, 1986

View PDFchevron_right

Serotonergic, noradrenergic, and dopaminergic measures in suicide brains

Belen Arranz

Biological Psychiatry, 1997

View PDFchevron_right

Noradrenergic function and HPA axis dysregulation in suicidal behaviour

Jussi Jokinen

Psychoneuroendocrinology, 2010

View PDFchevron_right

Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters

Eric Fertuck

Journal of Affective Disorders, 2006

View PDFchevron_right

Salivary cortisol and suicidal behavior - A follow

Daniel Lindqvist

2000

View PDFchevron_right

Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients

Kevin Malone

Biological Psychiatry, 1997

View PDFchevron_right

Salivary cortisol and suicidal behavior—A follow-up study

Anders Isaksson

Psychoneuroendocrinology, 2008

View PDFchevron_right

Increased Levels of Cortisol in Individuals With Suicide Attempt and Its Relation With the Number of Suicide Attempts and Depression

DIANA MARÍA GARCÍA

Frontiers in Psychiatry

View PDFchevron_right

Cortisol in violent suicidal behaviour: association with personality and monoaminergic activity

Kees Van Heeringen

Journal of Affective Disorders, 2000

View PDFchevron_right

Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt

Rolf Ekman

European Neuropsychopharmacology, 1999

View PDFchevron_right

Future Suicide Attempt and Responses to Serotonergic Challenge

Barbara Stanley

Neuropsychopharmacology, 2008

View PDFchevron_right

Arginine Vasopressin Is Associated with Hypercortisolemia and Suicide Attempts in Depression

Roger Mulder

Biological Psychiatry, 1997

View PDFchevron_right

Mood correlates with blood serotonin, but not with glucose measures in patients with recurrent suicidal behavior

Godfried van Kempen

Psychiatry Research, 1998

View PDFchevron_right

CSF 5-HIAA and DST non-suppression — Orthogonal biologic risk factors for suicide in male mood disorder inpatients

Jussi Jokinen

Psychiatry Research, 2009

View PDFchevron_right

Interaction between the serotonergic system and HPA and HPT axes in patients with major depression: implications for pathogenesis of suicidal behavior

Marie-Claude Mokrani

Dialogues in clinical neuroscience, 2002

View PDFchevron_right

Neurobiology of suicide: do biomarkers exist?

Sandra Burkhardt

International Journal Of Legal Medicine, 2013

View PDFchevron_right

Decreased aldosterone in the plasma of suicide attempters with major depressive disorder

Asa Westrin

Psychiatry Research, 2011

View PDFchevron_right

HPA-related CSF neuropeptides in suicide attempters

Rolf Ekman

European Neuropsychopharmacology, 1992

View PDFchevron_right

Relationship to Suicidal Behavior

Stephen Koslow

Annals of the New York Academy of Sciences, 1986

View PDFchevron_right

Biologic Alterations in the Brainstem of Suicides

Victoria Arango

Psychiatric Clinics of North America, 1997

View PDFchevron_right

Serotonergic mechanisms in brains of suicide victims

Raymond Lofthouse

Brain Research, 1986

View PDFchevron_right

CSF 5-HIAA predicts suicide risk after attempted suicide

Marie Asberg

Suicide & life-threatening behavior, 1994

View PDFchevron_right